January 9, 2025 - 19:58

Attorneys Heidi Urness and Rudy Cerone have shared insights into the opportunities available within the realm of distressed marijuana businesses. As the cannabis industry continues to evolve, many companies face significant challenges, creating a landscape ripe for investment and strategic partnerships.
Urness emphasizes the importance of due diligence when evaluating these businesses. She notes that understanding the underlying reasons for distress—be it financial mismanagement, regulatory hurdles, or market competition—is crucial in determining whether a business can be turned around.
Cerone adds that potential investors should look for signs of resilience and adaptability within a company. Factors such as a strong brand presence, a loyal customer base, and innovative product offerings can indicate a business's potential for recovery.
In a market that remains volatile, Urness and Cerone advocate for a cautious yet optimistic approach, encouraging stakeholders to recognize the unique opportunities that distressed marijuana businesses can offer.
August 7, 2026 - 01:20
Virginia businesses sue to block new THC regulations set to take effect this monthA group of Virginia business owners has filed a lawsuit to stop new state regulations on hemp products that are scheduled to kick in later this month. The rules, which take effect on August 16,...
August 6, 2026 - 23:17
Cardiologists share vaccine recommendations for heart patients: Flu, COVID-19 and moreThe American College of Cardiology has released updated guidance stressing that vaccination is a critical part of care for anyone living with cardiovascular disease. The new recommendations cover...
August 6, 2026 - 02:06
Amazon, Avril, Ferguson team up for housing as questions hang over WA's business climateSeattle`s given me a lot, Avril said. For me, it was all about just being able to pour back into the city that`s given me so much. That sentiment now anchors a new partnership between Amazon, the...
August 5, 2026 - 18:08
Clopidogrel monotherapy bests aspirin when patients with diabetes undergo PCIA fresh look at data from the SMART-CHOICE 3 trial suggests that diabetic patients who receive a coronary stent may do better on clopidogrel alone than on aspirin alone, once the standard initial...